Search results for: 'transformers ecg'
- Did you mean
- transformers eg
- transformers edg
- Related search terms
- Transformers market
- transformers low voltage
- ECG DEVICE MARKET
- Transformers environment
- ECG and Cardiac Monitoring Products
-
21 Jan 2025  |  Global  |  Technology Research
Technologies Enabling Resilient Pharmaceutical Supply Chains
AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network
This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging tec...
$4,950.00 -
26 Aug 2024  |  Global  |  Market Research
Precision Neurodegenerative Disease Market, Global, 2024 2028
Precision NDD Treatment is Experiencing Transformational Growth due to AI Capabilities, Disease-modifying Therapies, and Industry Convergence
The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...
$2,450.00 -
16 Jan 2025  |  Global  |  Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...
$4,950.00 -
10 Sep 2024  |  Global  |  Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...
$4,950.00 -
15 Jul 2024  |  Global  |  Technology Research
Connected Diabetes Care: Innovations and Growth Opportunities
Continuous Glucose Monitoring, Artificial Pancreas Systems, and Novel Insulin Delivery Formulations to Transform the Future of Diabetes Management
The preference for diabetes self-assessment using wearable CGMs instead of finger-stick blood sugar testing is increasing, especially in type 1 diabetics (T1D). HbA1c and time-in-range are currently the preferred biomarkers for diabetes monitoring applications. Emerging diet and fitness tracking apps help support general well-being and prevent the ...
$4,950.00 -
05 Aug 2024  |  Global  |  Technology Research
CGT Research Outlook and Technology Growth Opportunities
CGT Landscape Assessment
The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...
$4,950.00 -
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00 -
12 Jun 2024  |  Global  |  Market Research
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials
As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...
$2,450.00